Studies Point Way to Precision Therapies for Common Genetic Disorders

News   Feb 10, 2017 | Original story from Princeton University, Engineering School

 
Studies Point Way to Precision Therapies for Common Genetic Disorders

The researchers include: (from left) Trudi Schüpbach, the Henry Fairfield Osborn Professor of Biology; Rebecca Burdine, associate professor of molecular biology; Stanislav Shvartsman, Professor of Chemical and Biological Engineering and the Lewis Sigler Institute for Integrative Genomics; and Yogesh Goyal and Granton Jindal, graduate students in chemical and biological engineering.

 
 
 

RELATED ARTICLES

New Inherited Neurodevelopmental Disease Discovered

News

Researchers have identified a new inherited neurodevelopmental disease that causes slow growth, seizures and learning difficulties in humans.

READ MORE

XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

News

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.

READ MORE

BioAscent Establishes Integrated Drug Discovery Services Offering

News

Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE